The relative contribution of androgens and insulin in determining abdominal body fat distribution in premenopausal women.
To investigate the relative contribution of insulin and sex hormones in determining the abdominal pattern of fat distribution in premenopausal women, five groups of age-matched subjects were examined: Group 1 consisted of 14 normal weight eumenorrheic women (NO); Group 2 of 9 obese eumenorrheic women (OB); Group 3 of 14 normal weight hyperandrogenic women with polycystic ovary syndrome (NO-HA); Group 4 of 10 obese hyperandrogenic women with polycystic ovary syndrome (OB-HA) and, finally, Group 5 of 10 obese hyperandrogenic women with polycystic ovary syndrome and acanthosis nigricans (OB-HA-AN). Both the two normal weight groups and the three obese groups were matched for body mass index values. Sex hormone pattern showed significantly higher LH and testosterone levels in hyperandrogenic women with respect to NO and OB women but obese hyperandrogenic groups (OB-HA and OB-HA-AN) presented significantly lower LH concentrations than NO-HA. Fasting and glucose-stimulated insulin levels were significantly higher in OB than NO, in OB-HA and OB-HA-AN than in OB and NO-HA, and in OB-HA-AN than in OB-HA, without any significant difference between OB and NO-HA. Body fat distribution, expressed by the waist to hip ratio (WHR), showed progressively higher values (p less than 0.01) from NO to OB, NO-HA, OB-HA and, particularly, OB-HA-AN women. Determination coefficients r2 obtained from simple regression analysis showed that the sum of insulin values during the glucose tolerance test and testosterone levels had a more significant power in determining WHR variability.(ABSTRACT TRUNCATED AT 250 WORDS)
Pasquali
R
R
Istituto di Clinica Medica 1, University Alma Mater, Bologna, Italy.
Casimirri
F
F
Balestra
V
V
Flamia
R
R
Melchionda
N
N
Fabbri
R
R
Barbara
L
L
D000005:Abdomen / Q000033:anatomy & histology*; D000052:Acanthosis Nigricans / Q000378:metabolism / Q000473:pathology; D000273:Adipose Tissue / Q000378:metabolism*; D000328:Adult; D000728:Androgens / Q000502:physiology*; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D002096:C-Peptide / Q000378:metabolism; D005215:Fasting / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism; D012739:Gonadal Steroid Hormones / Q000032:analysis; D006062:Gonadotropins / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000502:physiology*; D008297:Male; D009765:Obesity / Q000378:metabolism / Q000473:pathology; D011085:Polycystic Ovary Syndrome / Q000378:metabolism / Q000473:pathology; D012044:Regression Analysis
D000728:Androgens; D001786:Blood Glucose; D002096:C-Peptide; D012739:Gonadal Steroid Hormones; D006062:Gonadotropins; D007328:Insulin; D005947:Glucose